Groowe Groowe / Newsroom / BTE
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BTE News

Baytex Energy Corp.

Baytex Announces Quarterly Dividend for October 2026 Ready to Announce with Confidence?

newsfilecorp.com
BTE

Baytex Announces Second Quarter 2026 Results; Production Guidance Raised on Strong Duvernay and Peavine Performance; Board Appointments Announced Ready to Announce with Confidence?

newsfilecorp.com
BTE

RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry

prnewswire.com
BIIB REGN GILD BTE BROS BFLY BCTX BCRX BTAI ALRS CAPR CRIS CYCN EXAS FATE GNTX HRMY INCY IONS KODK LAKE LULU MRNA NBIX NTRA OCGN ORGN PGEN PLRX RARE RGNX RXRX SAVA SGMO SNOW SRPT STEM TGTX TLSA TXG VRTX ZETA

Baytex Conference Call and Webcast on Second Quarter 2026 Results to Be Held on July 31, 2026 Ready to Announce with Confidence?

newsfilecorp.com
BTE

EnerCom Releases Presenter Lineup for the 31st EnerCom Denver - The Energy Investment Conference, August 17-19, 2026, in Denver, Colorado

prnewswire.com
WTTR E VOXR AMPY PED GTE BP VTS SM BKV BTE TXO EPSN WHK OKLO APA BSM MNR INDO FHN PROP SD DTI DNOW REI FISN REPX SLB GRNT LBRT FTW FET FTK

EnerCom Announces Liberty Energy as a Keynote Speaker at the 31st Annual EnerCom Denver- The Energy Investment Conference, August 17-19, 2026, in Denver, Colorado

prnewswire.com
BTE EPSN WHK OKLO APA BSM MNR FHN INDO PROP SD DTI DNOW REI REPX GRNT LBRT FTW FET FTK WTTR E VOXR AMPY PED GTE BP VTS SM BKV

Baytex Announces Renewal of Normal Course Issuer Bid Ready to Announce with Confidence?

newsfilecorp.com
BTE

Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape

globenewswire.com
KODK RKDA OTLK UTHR CLSD AZN BTE CCNE IONS APLS GYRO NVS GNTX BLTE JNJ LCTX ABBV REGN

Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

globenewswire.com
NVS TLX PFE EXEL LLY XNCR BTE ORIC MRK ABBV BMY AZN AMGN

Trans-Ocean Appoints Three to Internal Positions

accessnewswire.com
BTE